The American Pharmacists Association (APhA) has launched new and current training programs and resources to assist responders on the front lines of health care in staying safe and up to date with the latest research and practice guidance for the COVID-19 pandemic, it was reported on Tuesday.
APhA vice president, Professional Education Resources, Daniel Zlott, PharmD, BCOP, said, 'We are diligently working on behalf of pharmacists and patients to address the training needs of all as we face unprecedented times. Pharmacists can assist patients in a number of ways, including helping to increase the number of individuals who are able to be tested for COVID-19 and providing education to patients.'
The APhA's COVID-19 Specimen Collection Training guides pharmacists through the collection of nasopharyngeal swabs. The program will be adaptable to other testing methods once they become more widely available, such as nasal swabs, oral swabs, fingerstick tests, and other new technologies.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients